Sight Sciences officer proposes $130K share sale
The proposed shares came from restricted-stock vesting on June 30, 2026, and the sale includes an amount to cover a resulting tax obligation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sight Sciences, Inc. officer Alison Bauerlein reported a proposed sale of 24,184 common shares, with an aggregate market value of $129,502.91 and an approximate sale date of July 2, 2026. The shares were acquired through restricted stock vesting on June 30, 2026. The sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution.
During the prior three months, Bauerlein sold 25,874 shares on April 2, 2026, for gross proceeds of $90,007.90, and 12,728 shares on May 18, 2026, for gross proceeds of $65,129.18.
Key Figures
Key Terms
Restricted Stock Vesting financial
Aggregate Market Value financial
vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why does Alison Bauerlein’s SGHT sale include an amount for taxes?
AI-generated analysis. How Rhea-AI works. Not financial advice.